Loading
Latest filing published 12 Dec 2025 for Eton Pharmaceuticals, Inc., €1,224. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Ipek Erdogan-Trinkaus is known so far (12 December 2025): a share grant, €1,224, in Eton Pharmaceuticals, Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration